CN103222570A - 增强人体免疫力的碱性离子矿物质复合物食品添加剂 - Google Patents
增强人体免疫力的碱性离子矿物质复合物食品添加剂 Download PDFInfo
- Publication number
- CN103222570A CN103222570A CN201310109228XA CN201310109228A CN103222570A CN 103222570 A CN103222570 A CN 103222570A CN 201310109228X A CN201310109228X A CN 201310109228XA CN 201310109228 A CN201310109228 A CN 201310109228A CN 103222570 A CN103222570 A CN 103222570A
- Authority
- CN
- China
- Prior art keywords
- mineral complex
- immunity
- water
- complex food
- milligrams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052500 inorganic mineral Inorganic materials 0.000 title claims abstract description 67
- 239000011707 mineral Substances 0.000 title claims abstract description 67
- 230000036039 immunity Effects 0.000 title claims abstract description 52
- 235000013373 food additive Nutrition 0.000 title claims abstract description 31
- 239000002778 food additive Substances 0.000 title claims abstract description 31
- 230000002708 enhancing effect Effects 0.000 title claims abstract description 18
- 235000010755 mineral Nutrition 0.000 claims abstract description 66
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims abstract description 28
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims abstract description 28
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 17
- 229930006000 Sucrose Natural products 0.000 claims abstract description 17
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims abstract description 14
- 229910001629 magnesium chloride Inorganic materials 0.000 claims abstract description 14
- 229940072033 potash Drugs 0.000 claims abstract description 14
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims abstract description 14
- 235000015320 potassium carbonate Nutrition 0.000 claims abstract description 14
- 239000001103 potassium chloride Substances 0.000 claims abstract description 14
- 235000011164 potassium chloride Nutrition 0.000 claims abstract description 14
- 150000002500 ions Chemical class 0.000 claims description 31
- 239000003513 alkali Substances 0.000 claims description 30
- 239000005720 sucrose Substances 0.000 claims description 16
- 239000011734 sodium Substances 0.000 claims description 14
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 13
- 229910052708 sodium Inorganic materials 0.000 claims description 13
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 12
- 239000011777 magnesium Substances 0.000 claims description 12
- 239000011591 potassium Substances 0.000 claims description 12
- 229910052700 potassium Inorganic materials 0.000 claims description 12
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 11
- 229910052749 magnesium Inorganic materials 0.000 claims description 11
- -1 D-D-sorbite Chemical compound 0.000 claims description 8
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 6
- 238000010304 firing Methods 0.000 claims description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 5
- 235000019738 Limestone Nutrition 0.000 claims description 3
- 239000001569 carbon dioxide Substances 0.000 claims description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 235000019628 coolness Nutrition 0.000 claims description 3
- 239000006028 limestone Substances 0.000 claims description 3
- 229910052698 phosphorus Inorganic materials 0.000 claims description 3
- 238000004062 sedimentation Methods 0.000 claims description 3
- 238000009423 ventilation Methods 0.000 claims description 3
- 239000011701 zinc Substances 0.000 claims description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 2
- 239000000470 constituent Substances 0.000 claims description 2
- 229910052802 copper Inorganic materials 0.000 claims description 2
- 239000010949 copper Substances 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- 239000011574 phosphorus Substances 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 25
- 241000282414 Homo sapiens Species 0.000 abstract description 17
- 206010028980 Neoplasm Diseases 0.000 abstract description 11
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 abstract description 6
- 201000011510 cancer Diseases 0.000 abstract description 4
- 230000002265 prevention Effects 0.000 abstract description 4
- 208000035473 Communicable disease Diseases 0.000 abstract description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract description 2
- 239000000654 additive Substances 0.000 abstract 2
- 230000000996 additive effect Effects 0.000 abstract 2
- 206010061598 Immunodeficiency Diseases 0.000 abstract 1
- 150000001450 anions Chemical class 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 229960002337 magnesium chloride Drugs 0.000 abstract 1
- 229960002816 potassium chloride Drugs 0.000 abstract 1
- 230000000191 radiation effect Effects 0.000 abstract 1
- 229960002920 sorbitol Drugs 0.000 abstract 1
- 229960004793 sucrose Drugs 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 26
- 210000004369 blood Anatomy 0.000 description 15
- 239000008280 blood Substances 0.000 description 15
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 230000006870 function Effects 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 230000033001 locomotion Effects 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- 206010010356 Congenital anomaly Diseases 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000000890 antigenic effect Effects 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 230000007969 cellular immunity Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229940124597 therapeutic agent Drugs 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 102100036242 HLA class II histocompatibility antigen, DQ alpha 2 chain Human genes 0.000 description 2
- 101000930801 Homo sapiens HLA class II histocompatibility antigen, DQ alpha 2 chain Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010029719 Nonspecific reaction Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000004727 humoral immunity Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000003507 refrigerant Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000002889 sympathetic effect Effects 0.000 description 2
- 230000004614 tumor growth Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 210000000612 antigen-presenting cell Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 238000002659 cell therapy Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000007236 host immunity Effects 0.000 description 1
- 230000008076 immune mechanism Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000005007 innate immune system Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000002977 intracellular fluid Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 235000020825 overweight Nutrition 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 210000005105 peripheral blood lymphocyte Anatomy 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001835 salubrious effect Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Images
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310109228.XA CN103222570B (zh) | 2013-03-29 | 2013-03-29 | 增强人体免疫力的碱性离子矿物质复合物食品添加剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310109228.XA CN103222570B (zh) | 2013-03-29 | 2013-03-29 | 增强人体免疫力的碱性离子矿物质复合物食品添加剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103222570A true CN103222570A (zh) | 2013-07-31 |
CN103222570B CN103222570B (zh) | 2014-07-16 |
Family
ID=48833403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310109228.XA Active CN103222570B (zh) | 2013-03-29 | 2013-03-29 | 增强人体免疫力的碱性离子矿物质复合物食品添加剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103222570B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106138095A (zh) * | 2015-04-07 | 2016-11-23 | 华盛鑫丰(北京)能源发展有限公司 | 利用贝壳类和/或堆积石灰岩烧制的水溶性矿物粉及其制作方法和应用 |
CN106490601A (zh) * | 2016-10-21 | 2017-03-15 | 青岛首创嘉业工贸有限公司 | 一种活性保健品及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1593458A (zh) * | 2004-06-18 | 2005-03-16 | 魏国平 | 速溶营养强化剂 |
CN101077191A (zh) * | 2006-05-23 | 2007-11-28 | 杨康康 | 亚健康防癌营养剂 |
CN101228915A (zh) * | 2007-01-23 | 2008-07-30 | 丁庆 | 珊瑚钙含片 |
CN101559075A (zh) * | 2008-04-16 | 2009-10-21 | 邱于恺 | 生物活性钙离子组成物及其制造方法 |
CN102716154A (zh) * | 2012-06-28 | 2012-10-10 | 舒文一 | 离子钙水溶性制剂的加工方法及产品 |
CN102919666A (zh) * | 2012-11-12 | 2013-02-13 | 沈阳信达信息科技有限公司 | 一种钙片 |
-
2013
- 2013-03-29 CN CN201310109228.XA patent/CN103222570B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1593458A (zh) * | 2004-06-18 | 2005-03-16 | 魏国平 | 速溶营养强化剂 |
CN101077191A (zh) * | 2006-05-23 | 2007-11-28 | 杨康康 | 亚健康防癌营养剂 |
CN101228915A (zh) * | 2007-01-23 | 2008-07-30 | 丁庆 | 珊瑚钙含片 |
CN101559075A (zh) * | 2008-04-16 | 2009-10-21 | 邱于恺 | 生物活性钙离子组成物及其制造方法 |
CN102716154A (zh) * | 2012-06-28 | 2012-10-10 | 舒文一 | 离子钙水溶性制剂的加工方法及产品 |
CN102919666A (zh) * | 2012-11-12 | 2013-02-13 | 沈阳信达信息科技有限公司 | 一种钙片 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106138095A (zh) * | 2015-04-07 | 2016-11-23 | 华盛鑫丰(北京)能源发展有限公司 | 利用贝壳类和/或堆积石灰岩烧制的水溶性矿物粉及其制作方法和应用 |
CN106490601A (zh) * | 2016-10-21 | 2017-03-15 | 青岛首创嘉业工贸有限公司 | 一种活性保健品及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103222570B (zh) | 2014-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7054909B2 (ja) | 細菌株を含む組成物 | |
Campbell-McBride | Gut and psychology syndrome: Natural treatment for autism, dyspraxia, ADD, dyslexia, ADHD, depression, schizophrenia | |
Shirzad et al. | Does Royal jelly affect tumor cells? | |
HUE035426T2 (hu) | Probiotikus és prebiotikus komponenseket és ásványi sókat tartalmazó készítmények laktoferrinnel | |
CN108271355A (zh) | 包含细菌菌株的组合物 | |
CN108271354A (zh) | 包含细菌菌株的组合物 | |
EA200701519A1 (ru) | Живая аттенуированная ротавирусная вакцина для перорального введения | |
CN105555150A (zh) | 用于增强免疫的组合物 | |
CN102160664A (zh) | 儿童营养饮料 | |
CN104171735A (zh) | 海参喂养用全价配合饲料 | |
CN103222570B (zh) | 增强人体免疫力的碱性离子矿物质复合物食品添加剂 | |
Azhir et al. | Effect of ginger powder rhizome on homural immunity of broiler chickens | |
CN103783238A (zh) | 儿童益智型牦牛乳蛋白质糖及其制备方法 | |
KR102348278B1 (ko) | 녹용, 야관문, 용안육 및 구기자 추출물을 함유하는 건강식품 조성물 제조방법 및 이에 의해 제조된 건강식품 조성물 | |
CN102058884B (zh) | 一种草鱼注射疫苗增效剂及其制备方法 | |
Chirigos et al. | Characterization of agents | |
Sloan | Cancer: The Metabolic Disease Unravelled | |
Yellowdawn | The sun, human & food: A self-treatment and practice with natural food | |
Van Hamme | Managing intestinal health through a preventative approach | |
CN101579293A (zh) | 用于预防口腔龋齿的IgY抗体清洁剂 | |
CN106215022A (zh) | 一种含点地梅利咽中药及制备方法 | |
KR101253096B1 (ko) | 야콘과 콜라겐을 함유하는 새로운 향미의 마른김(乾海苔) 조성물과 그 제조방법 | |
JP5756270B2 (ja) | がんペプチドワクチン療法効果向上剤 | |
RU2010141597A (ru) | Способ лечения онкологических заболеваний | |
KR20100048707A (ko) | 인진쑥 발효액을 유효성분으로 하는 조성물, 그 제조방법 및 이를 이용한 건강식품, 말운동계질환 치료제 및 보조사료, 동물의 백내장치료제, 개 parvo 치료제 및 그 치료방법. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200701 Address after: 101599 pollution free vegetable base in nanjingoutun village, Henan Zhai Town, Miyun District, Beijing Co-patentee after: Wang Yongjun Patentee after: Cui Shunzhe Address before: Henan Zhai Zhen Nan Jin Gou Tun Cun 101599 Beijing city Miyun pollution-free vegetable base Patentee before: Cui Shunzhe |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240112 Address after: 101599 Nanjingoutun Village, Henan Zhai Town, Miyun District, Beijing, Pollution free Vegetable Base Patentee after: Cui Shunzhe Patentee after: Fujian Hongkangtang Biotechnology Co.,Ltd. Address before: 101599 Nanjingoutun Village, Henan Zhai Town, Miyun District, Beijing, Pollution free Vegetable Base Patentee before: Cui Shunzhe Patentee before: Wang Yongjun |
|
TR01 | Transfer of patent right |